The antiviral drug remdesivir has shown promise in treating the COVID-19 infection in hospitalized patients. Dr. Mark McClellan, a professor of Business, Medicine and Policy at Duke University and a former FDA commissioner, joins CBSN's Reena Ninan for a closer look at the drug.
